NCT05567575

Brief Summary

Onset of First Episode Psychosis (FEP) is at a young age and is a critical period influencing the long-term course of the disorder. Failure to identify FEP can lead to serious implications such as disruption of education, reduced long-term employment, huge economic burden, and is associated with significantly higher mortality. The prevalence of psychosis increases rapidly from age 14 onwards with a peak incidence in the late teens and early 20s. The aim of the project is to examine the acceptability and feasibility of a mobile phone application-based intervention 'TechCare-PK', for individuals with psychosis in Pakistan. The main objectives are to determine whether appropriate individuals could be identified and recruited to the study and whether the TechCare App would be an acceptable intervention for individuals with psychosis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 5, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

2.2 years

First QC Date

October 1, 2022

Last Update Submit

May 16, 2024

Conditions

Keywords

PsychosismHealthTechonologyLMICs

Outcome Measures

Primary Outcomes (2)

  • Feasibility measures

    Feasibility will be determined by recruitment rates, adherence rate and retention rates. The criterion for success of feasibility is to recruit \>50% of eligible participants, adherence rate (number of home assignments completed; \> 50%) and retention rate of 70%

    From baseline to 3rd month (at the end of intervention)

  • Acceptability measure

    Acceptability will be determined using participant feedback on the use of app

    From baseline to 3rd month (at the end of intervention)

Secondary Outcomes (6)

  • Positive and Negative Syndrome Scale

    Changes from baseline to week-12

  • Psychotic Symptom Rating Scales (PSYRATS)

    Changes from baseline to week-12

  • Calgary Depression Scale (CDS)

    Changes from baseline to week-12

  • The Work and Social Adjustment Scale (WSAS)

    Changes from baseline to week-12

  • EuroQol-5 Dimensions EQ5-D

    Changes from baseline to week-12

  • +1 more secondary outcomes

Study Arms (2)

TechCare

EXPERIMENTAL

Participants in this arm will receive a mobile app based cognitive behavior therapy informed "TechCare" intervention for a period of 12 weeks.

Behavioral: Cognitive Behavioral Therapy,

Wait-List control group:

ACTIVE COMPARATOR

Participants in this arm will be offered the intervention once the intervention arm have completed their 3rd month outcome assessment.

Behavioral: Cognitive Behavioral Therapy,

Interventions

TechCare is based on the intelligent real time therapy (iRTT) conceptual model proposed by Kelly et al. iRTT relates to the use of mobile technologies to deliver interventions such as CBT, extending beyond assessment of symptoms. The intervention is based on the treatment manual developed by David G. Kingdon and Douglas Turkington. The intervention is informed by evidence based cognitive models of psychosis, where the participant is able to choose from a list of pre-selected digital self-help strategies that are personalised to each participant. For example, the App may incorporate the participant's favourite music in the form of multimedia or YouTube links, which are prompted during symptom elevation. Other examples may include psychoeducation, goal setting, problem-solving, etc., based on common self-help strategies in CBT for Psychosis (CBTp).

Also known as: Mobile Health
TechCareWait-List control group:

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and Females patients diagnosed with FEP- Schizophrenia or Schizoaffective disorder.
  • Over the age of 18 years.
  • A score of three or more on any of the positive symptoms on the PANSS
  • A Minimum score of one on the Calgary Depression scale (CDS)
  • Having smart phone and able to use smart phone functions.
  • Able to understand written and spoken Urdu.

You may not qualify if:

  • unable to use simple functions of an android phone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institute of Psychiatry

Rawalpindi, Punjab Province, Pakistan

RECRUITING

Civil Hospital

Karachi, Sindh, 75500, Pakistan

RECRUITING

MeSH Terms

Conditions

Psychotic Disorders

Interventions

Cognitive Behavioral TherapyTelemedicine

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Omair Husain, MD

    Centre for Addiciton and Mental Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ameer B Khoso, Mphil

CONTACT

Zaib un Nisa, Mphil

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Researchers doing outcome assessments will be kept masked of the treatment allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2022

First Posted

October 5, 2022

Study Start

October 1, 2022

Primary Completion

December 30, 2024

Study Completion

July 31, 2025

Last Updated

May 17, 2024

Record last verified: 2024-05

Locations